His primary areas of investigation include Genetics, Melanoma, Germline mutation, CDKN2A and Cutaneous melanoma. The subject of his Melanoma research is within the realm of Cancer research. His Cancer research research includes themes of Bioinformatics, Transcription factor, Oncogene, Chromatin and microRNA.
The study incorporates disciplines such as Telomere, Point mutation, Family history and Germline in addition to Germline mutation. The concepts of his Oncology study are interwoven with issues in Cancer, Performance status, Pathology, Genotype and Ipilimumab. His work carried out in the field of Gene brings together such families of science as Binimetinib, Subclass and Adenocarcinoma.
His scientific interests lie mostly in Melanoma, Cancer research, Genetics, Internal medicine and CDKN2A. His study in Melanoma focuses on Cutaneous melanoma in particular. His Cutaneous melanoma study incorporates themes from Dermatology, Nevus, Case-control study and MEDLINE.
His study in Cancer research is interdisciplinary in nature, drawing from both Exome sequencing, Cell cycle, Loss of heterozygosity and p14arf. His Internal medicine research is multidisciplinary, incorporating elements of Oncology and Pathology. The various areas that he examines in his Oncology study include Stage and Bioinformatics.
His primary scientific interests are in Melanoma, Cutaneous melanoma, Cancer research, Internal medicine and Oncology. His Melanoma research entails a greater understanding of Genetics. His studies deal with areas such as Genome-wide association study, MEDLINE, Case-control study, Germline and CDKN2A as well as Cutaneous melanoma.
Graham J. Mann studied CDKN2A and Genetic testing that intersect with Germline mutation and Genetic counseling. Graham J. Mann has included themes like Microvesicles, microRNA, Gene and Gene mutation in his Cancer research study. His Oncology research is multidisciplinary, relying on both Cancer, Adenocarcinoma and Confidence interval.
His main research concerns Melanoma, Cancer research, Cutaneous melanoma, Cancer and Internal medicine. His Melanoma research is multidisciplinary, incorporating perspectives in Metastasis and Neuroblastoma RAS viral oncogene homolog. His Cutaneous melanoma study is concerned with the field of Genetics as a whole.
His Genetics study focuses on Germline mutation in particular. His Cancer research includes elements of Mutation and Gene regulatory network. His Internal medicine research is multidisciplinary, relying on both Gene, Oncology, MAPK/ERK pathway and Gene expression profiling.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Genomic Classification of Cutaneous Melanoma
Rehan Akbani;Kadir C. Akdemir;B. Arman Aksoy;Monique Albert.
Pan-cancer analysis of whole genomes
Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart.
Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma
Georgina V. Long;Alexander M. Menzies;Adnan M. Nagrial;Lauren E. Haydu.
Journal of Clinical Oncology (2011)
Whole-genome landscapes of major melanoma subtypes
Nicholas K. Hayward;Nicholas K. Hayward;James S. Wilmott;Nicola Waddell;Nicola Waddell;Peter A. Johansson.
Geographical Variation in the Penetrance of CDKN2A Mutations for Melanoma
D. Timothy Bishop;Florence Demenais;Alisa M. Goldstein;Wilma Bergman.
Journal of the National Cancer Institute (2002)
Genomic and Functional Approaches to Understanding Cancer Aneuploidy
Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao.
Cancer Cell (2018)
Genome-wide association study identifies three loci associated with melanoma risk.
D Timothy Bishop;Florence Demenais;Mark M Iles;Mark Harland.
Nature Genetics (2009)
A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma
Satoru Yokoyama;Susan L. Woods;Glen M. Boyle;Lauren G. Aoude.
Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma‐prone families from three continents
Alisa M Goldstein;May Chan;Mark Harland;Nicholas K Hayward.
Journal of Medical Genetics (2006)
High-risk Melanoma Susceptibility Genes and Pancreatic Cancer, Neural System Tumors, and Uveal Melanoma across GenoMEL
Alisa M. Goldstein;May Chan;Mark Harland;Elizabeth M. Gillanders.
Cancer Research (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: